Refined glioma classification based on molecular pathology

研究成果: ジャーナルへの寄稿記事

抄録

The Cancer Genome Atlas (TCGA), which is a multidimensional and comprehensive analyses of genomic/epigenomic alterations, has identified novel molecular changes on multiple regulatory levels (genomic, transcriptional, epigenomic) in human gliomas. The development of new technologies, such as next generation sequencing, has accelerated systematic studies of the cancer genome in recent years. Accordingly, our understanding has rapidly expanded, and some of the newly discovered molecular alterations are critical for the application of personalized medicine. These kinds of analyses have, however, also revealed the complexity of the glioma molecular basis. In this review, we will summarize these novel genetic/epigenetic insights into the nature of glioma, and further discuss its genomic complexity.

元の言語英語
ページ(範囲)366-377
ページ数12
ジャーナルJapanese Journal of Neurosurgery
24
発行部数6
DOI
出版物ステータス出版済み - 1 1 2015

Fingerprint

Molecular Pathology
Epigenomics
Glioma
Genome
Precision Medicine
Atlases
Neoplasms
Technology

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

これを引用

Refined glioma classification based on molecular pathology. / Mizoguchi, Masahiro.

:: Japanese Journal of Neurosurgery, 巻 24, 番号 6, 01.01.2015, p. 366-377.

研究成果: ジャーナルへの寄稿記事

@article{12cb789c5252401faca8b36b3da886a4,
title = "Refined glioma classification based on molecular pathology",
abstract = "The Cancer Genome Atlas (TCGA), which is a multidimensional and comprehensive analyses of genomic/epigenomic alterations, has identified novel molecular changes on multiple regulatory levels (genomic, transcriptional, epigenomic) in human gliomas. The development of new technologies, such as next generation sequencing, has accelerated systematic studies of the cancer genome in recent years. Accordingly, our understanding has rapidly expanded, and some of the newly discovered molecular alterations are critical for the application of personalized medicine. These kinds of analyses have, however, also revealed the complexity of the glioma molecular basis. In this review, we will summarize these novel genetic/epigenetic insights into the nature of glioma, and further discuss its genomic complexity.",
author = "Masahiro Mizoguchi",
year = "2015",
month = "1",
day = "1",
doi = "10.7887/jcns.24.366",
language = "English",
volume = "24",
pages = "366--377",
journal = "Japanese Journal of Neurosurgery",
issn = "0917-950X",
publisher = "Japanese Congress of Neurological Surgeons",
number = "6",

}

TY - JOUR

T1 - Refined glioma classification based on molecular pathology

AU - Mizoguchi, Masahiro

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The Cancer Genome Atlas (TCGA), which is a multidimensional and comprehensive analyses of genomic/epigenomic alterations, has identified novel molecular changes on multiple regulatory levels (genomic, transcriptional, epigenomic) in human gliomas. The development of new technologies, such as next generation sequencing, has accelerated systematic studies of the cancer genome in recent years. Accordingly, our understanding has rapidly expanded, and some of the newly discovered molecular alterations are critical for the application of personalized medicine. These kinds of analyses have, however, also revealed the complexity of the glioma molecular basis. In this review, we will summarize these novel genetic/epigenetic insights into the nature of glioma, and further discuss its genomic complexity.

AB - The Cancer Genome Atlas (TCGA), which is a multidimensional and comprehensive analyses of genomic/epigenomic alterations, has identified novel molecular changes on multiple regulatory levels (genomic, transcriptional, epigenomic) in human gliomas. The development of new technologies, such as next generation sequencing, has accelerated systematic studies of the cancer genome in recent years. Accordingly, our understanding has rapidly expanded, and some of the newly discovered molecular alterations are critical for the application of personalized medicine. These kinds of analyses have, however, also revealed the complexity of the glioma molecular basis. In this review, we will summarize these novel genetic/epigenetic insights into the nature of glioma, and further discuss its genomic complexity.

UR - http://www.scopus.com/inward/record.url?scp=84933040018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933040018&partnerID=8YFLogxK

U2 - 10.7887/jcns.24.366

DO - 10.7887/jcns.24.366

M3 - Article

AN - SCOPUS:84933040018

VL - 24

SP - 366

EP - 377

JO - Japanese Journal of Neurosurgery

JF - Japanese Journal of Neurosurgery

SN - 0917-950X

IS - 6

ER -